West Pharmaceutical Services, Inc. (NYSE: WST)
Health Care · Life Sciences Tools & Services · US
$353.32
+0.07% today · +42.9% 1Y
West Pharmaceutical Services, Inc. (NYSE: WST) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $24.87B and employs 10,800 people.
Over the last twelve months the share price has gained 42.9%, trading between 223.83 and 386.00.
Tweenvest scores West Pharmaceutical Services, Inc. across four factors: quality 84/100, value 42/100, growth 40/100, dividend 62/100. Its strongest factor is quality.
WST price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.87B
- Revenue (TTM)
- $3.33B
- P/E
- 45.24
- EPS
- 7.81
- Dividend yield
- 0.25%
- Beta (5Y)
- 1.14
- 52-week high
- $386.00
- 52-week low
- $223.83
- Avg volume (3M)
- —
- Shares outstanding
- 70.38M
- Employees
- 10,800
- Next earnings
- —
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- ISIN
- US9553061055
- Founded
- 1923
- Listed since
- Mar 17, 1980
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.47B | $629.00 | +0.04% |
| Danaher CorporationNYSE: DHR | $151.22B | $215.00 | -0.05% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $69.06B | CN¥155.84 | -4.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.21B | CHF593.40 | +0.95% |
| Agilent Technologies, Inc.NYSE: A | $43.33B | $153.43 | -3.50% |
| IQVIA Holdings Inc.NYSE: IQV | $42.84B | $260.24 | +0.16% |
| Waters CorporationNYSE: WAT | $40.36B | $410.75 | +0.01% |
Figures last refreshed Aug 18, 2026.